OLAPARIBE 150 MG COM REV CT BL AL AL X 56
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1826100310079 -
GGREM
573026100009607 -
Código de barras
7898565166117
O que a fonte publica
- Detentor do registro
- NATCOFARMA DO BRASIL LTDA
- Princípios ativos
- OLAPARIBE
- Embalagem
- 150 MG COM REV CT BL AL AL X 56
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Genérico
- Classe terapêutica
- L1K - ANTINEOPLÁSICOS LIDOMIDA
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "OLAPARIBE 150 MG COM REV CT BL AL AL X 56",
"holder": "NATCOFARMA DO BRASIL LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7898565166117"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "573026100009607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": true,
"holderTaxId": "08.157.293/0001-27",
"priceRegime": "Regulado",
"productName": "OLAPARIBE",
"productType": "Genérico",
"hospitalOnly": false,
"presentation": "150 MG COM REV CT BL AL AL X 56",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "10030.70",
"icms-12": "11398.53",
"icms-17": "12085.18",
"icms-18": "12232.56",
"icms-19": "12383.58",
"icms-20": "12538.38",
"icms-21": "12697.09",
"icms-22": "12859.87",
"icms-23": "13026.88",
"icms-17.5": "12158.42",
"icms-19.5": "12460.50",
"icms-20.5": "12617.24",
"icms-22.5": "12942.84",
"icms-12-alc": "10177.26",
"icms-17-alc": "10790.33",
"icms-18-alc": "10921.93",
"icms-19-alc": "11056.76",
"icms-20-alc": "11194.97",
"icms-21-alc": "11336.69",
"icms-22-alc": "11482.02",
"icms-23-alc": "11631.14",
"withoutTaxes": "8955.98",
"icms-17.5-alc": "10855.74",
"icms-19.5-alc": "11125.44",
"icms-20.5-alc": "11265.38",
"icms-22.5-alc": "11556.10"
},
"pisCofinsList": "Negativa",
"substanceText": "OLAPARIBE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "13455.83",
"icms-12": "15290.72",
"icms-17": "16211.84",
"icms-18": "16409.54",
"icms-19": "16612.13",
"icms-20": "16819.79",
"icms-21": "17032.69",
"icms-22": "17251.06",
"icms-23": "17475.10",
"icms-17.5": "16310.09",
"icms-19.5": "16715.32",
"icms-20.5": "16925.58",
"icms-22.5": "17362.36",
"icms-12-alc": "14069.46",
"icms-17-alc": "14917.00",
"icms-18-alc": "15098.93",
"icms-19-alc": "15285.32",
"icms-20-alc": "15476.39",
"icms-21-alc": "15672.31",
"icms-22-alc": "15873.22",
"icms-23-alc": "16079.37",
"withoutTaxes": "12381.12",
"icms-17.5-alc": "15007.42",
"icms-19.5-alc": "15380.27",
"icms-20.5-alc": "15573.73",
"icms-22.5-alc": "15975.63"
},
"invalidBarcodes": [],
"activeSubstances": [
"OLAPARIBE"
],
"therapeuticClass": "L1K - ANTINEOPLÁSICOS LIDOMIDA",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1826100310079",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L1K",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:573026100009607"